Published in J Infect Dis on May 01, 1992
Maternal vaccination: moving the science forward. Hum Reprod Update (2014) 1.50
Placental antibody transfer: influence of maternal HIV infection and placental malaria. Arch Dis Child Fetal Neonatal Ed (1998) 1.27
The Vi conjugate typhoid vaccine is safe, elicits protective levels of IgG anti-Vi, and is compatible with routine infant vaccines. Clin Vaccine Immunol (2011) 1.12
Anticarrier immunity suppresses the antibody response to polysaccharide antigens after intranasal immunization with the polysaccharide-protein conjugate. Infect Immun (1997) 0.94
A cohort study of developmental polychlorinated biphenyl (PCB) exposure in relation to post-vaccination antibody response at 6-months of age. Environ Res (2010) 0.88
Immunization of female mice with glycoconjugates protects their offspring against encapsulated bacteria. Infect Immun (2004) 0.78
The potential of immunization with synthetic peptides to overcome the immunosuppressive effect of maternal anti-measles virus antibodies in young mice. Immunology (1994) 0.75
Protective levels of polysaccharide-specific maternal antibodies may enhance the immune response elicited by pneumococcal conjugates in neonatal and infant mice. Infect Immun (2005) 0.75
Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med (2001) 10.56
Lipopolysaccharide heterogeneity in Salmonella typhimurium analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis. Eur J Biochem (1980) 8.05
Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet (1988) 7.59
Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. J Infect Dis (1983) 6.15
Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis. Lancet (1983) 5.63
The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis (1983) 4.05
Serotypes, hemolysin production, and receptor recognition of Escherichia coli strains associated with neonatal sepsis and meningitis. Infect Immun (1985) 4.01
F + , Hfr, and F' strains of Salmonella typhimurium and Salmonella abony. Bacteriol Rev (1972) 3.73
Recent primary toxoplasma infection indicated by a low avidity of specific IgG. J Infect Dis (1989) 3.67
P-fimbriated clones among uropathogenic Escherichia coli strains. Infect Immun (1984) 3.50
Mannose-resistant haemagglutination and P antigen recognition are characteristic of Escherichia coli causing primary pyelonephritis. Lancet (1982) 3.39
Prevention of Hemophilus influenzae type b bacteremic infections with the capsular polysaccharide vaccine. N Engl J Med (1984) 3.37
The complement regulator factor H binds to the surface protein OspE of Borrelia burgdorferi. J Biol Chem (2000) 3.24
Separation of normal and immune lymphoid cells by antigen-coated coated columns. Antigen-binding characteristics of membrane antibodies as analyzed by hapten-protein antigens. J Exp Med (1970) 3.08
Characterization of the lipopolysaccharide from the polymyxin-resistant pmrA mutants of Salmonella typhimurium. FEBS Lett (1981) 2.91
A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease. N Engl J Med (1990) 2.90
Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine. J Infect Dis (1991) 2.83
Polysaccharide vaccines of group A Neisseria meningtitidis and Haemophilus influenzae type b: a field trial in Finland. J Infect Dis (1977) 2.79
Effect of the number of haptens coupled to each erythrocyte on haemolytic plaque formation. Immunology (1969) 2.71
The role of cell number and source in adoptive immunity. Immunology (1965) 2.68
The effect of antigen dosage on the response of adoptively transferred cells. Immunology (1965) 2.59
Immunization with major outer membrane proteins in experimental salmonellosis of mice. Infect Immun (1979) 2.53
Effect of polymyxin on the ultrastructure of the outer membrane of wild-type and polymyxin-resistant strain of Salmonella. J Bacteriol (1976) 2.43
Enterobacterial common antigen. Bacteriol Rev (1976) 2.41
Inherited immunoglobulin idiotypes of the mouse. Immunol Rev (1977) 2.29
The genus-specific antigen of Chlamydia: resemblance to the lipopolysaccharide of enteric bacteria. Science (1983) 2.22
Recurrence of urinary tract infection in a primary care setting: analysis of a 1-year follow-up of 179 women. Clin Infect Dis (1996) 2.15
Complement evasion by Borrelia burgdorferi: serum-resistant strains promote C3b inactivation. Infect Immun (2001) 2.03
Bacteriophage-resistant mutants of Salmonella typhimurium deficient in two major outer membrane proteins. J Bacteriol (1976) 2.02
Comparison of a new tumour marker, CA 19-9, with alpha-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases. J Clin Pathol (1984) 1.98
Effect of group-A meningococcal vaccine in army recruits in Finland. Lancet (1975) 1.97
Evaluation of CA 19-9 as a serum tumour marker in pancreatic cancer. Br J Cancer (1986) 1.91
A new gene cluster rfe concerned with the biosynthesis of Salmonella lipopolysaccharide. J Gen Microbiol (1970) 1.91
Soluble antigen-antibody complexes and platelet aggregation. Acta Pathol Microbiol Scand (1969) 1.91
Risk factors for pneumonia in the elderly. Am J Med (1994) 1.89
The role of IFN-gamma in murine Salmonella typhimurium infection. Microb Pathog (1990) 1.84
Inheritance of antibody specificity. I. Anti-(4-hydroxy-3-nitrophenyl)acetyl of the mouse primary response. J Exp Med (1974) 1.82
Genetic determination of the O antigens of Salmonella groups B (4,5,12) and C1(6,7). J Bacteriol (1966) 1.81
Lipopolysaccharide nomenclature--past, present, and future. J Bacteriol (1986) 1.80
Inheritance of the O antigens of Salmonella groups B and D. J Gen Microbiol (1965) 1.79
New Salmonella typhimurium mutants with altered outer membrane permeability. J Bacteriol (1984) 1.76
Cleavage of the polysialosyl units of brain glycoproteins by a bacteriophage endosialidase. Involvement of a long oligosaccharide segment in molecular interactions of polysialic acid. J Biol Chem (1985) 1.71
Strain differences in the fine specificity of mouse anti-hapten antibodies. Eur J Immunol (1973) 1.69
A novel virulence-associated cell surface structure composed of 47-kd protein subunits in Yersinia enterocolitica. EMBO J (1985) 1.68
Basement membrane carbohydrate as a target for bacterial adhesion: binding of type I fimbriae of Salmonella enterica and Escherichia coli to laminin. Mol Microbiol (1993) 1.66
Serum antibodies after vaccination with Haemophilus influenzae type b capsular polysaccharide and responses to reimmunization: no evidence of immunologic tolerance or memory. Pediatrics (1984) 1.65
Genetic aspects of biosynthesis and structure of Salmonella somatic polysaccharide. Ann N Y Acad Sci (1966) 1.64
An outer membrane-disorganizing peptide PMBN sensitizes E. coli strains to serum bactericidal action. J Immunol (1984) 1.62
Isolated hapten-binding receptors of sensitized lymphocytes. I. Receptors from nylon wool-enriched mouse T lymphocytes lack serological markers of immunoglobulin constant domains but express heavy chain variable portions. Eur J Immunol (1977) 1.61
Mutants defective in the 33K outer membrane protein of Salmonella typhimurium. J Bacteriol (1979) 1.60
The bacteriology of acute otitis media in children with special reference to Streptococcus pneumoniae as studied by bacteriological and antigen detection methods. Scand J Infect Dis (1981) 1.59
Etiology of childhood pneumonia: serologic results of a prospective, population-based study. Pediatr Infect Dis J (1998) 1.59
Genetic determination of enzymes synthesizing O-specific sugars of Salmonella lipopolysaccharides. J Bacteriol (1966) 1.58
Role of O-antigen (lipopolysaccharide) factors in the virulence of Salmonella. J Infect Dis (1973) 1.57
Activation of the alternative pathway of complement by monoclonal lambda light chains in membranoproliferative glomerulonephritis. J Exp Med (1992) 1.56
Comparison of CA 19-9 and carcinoembryonic antigen (CEA) levels in the serum of patients with colorectal diseases. Br J Cancer (1984) 1.56
The diversity and specialization of immunocytes. Prog Allergy (1970) 1.54
Serum antibodies to capsular polysaccharide vaccine of group A Neissera meningitidis followed for three years in infants and children. J Infect Dis (1980) 1.53
Anti-oxazolone hybridomas and the structure of the oxazolone idiotype. J Immunol (1983) 1.52
Participation of lipopolysaccharide genes in the determination of the enterobacterial common antigen: analysis of R mutants of Salmonella minnesota. J Bacteriol (1974) 1.52
Antibody levels achieved in infants by course of Haemophilus influenzae type B polysaccharide/diphtheria toxoid conjugate vaccine. Lancet (1985) 1.52
Clinical efficacy of pneumococcal vaccine in the elderly: a randomized, single-blind population-based trial. Am J Med (1997) 1.50
Assay of anti-hapten antibody with the aid of hapten-coupled bacteriophage. Immunology (1966) 1.48
Protein K: a new major outer membrane protein found in encapsulated Escherichia coli. J Bacteriol (1979) 1.47
Microbial etiology of community-acquired pneumonia in the adult population of 4 municipalities in eastern Finland. Clin Infect Dis (2001) 1.47
Phagocytosis of bacteria by macrophages: changing the carbohydrate of lipopolysaccharide alters interaction with complement and macrophages. J Immunol (1982) 1.45
Immunologically related ketodeoxyoctonate-containing structures in Chlamydia trachomatis, Re mutants of Salmonella species, and Acinetobacter calcoaceticus var. anitratus. Infect Immun (1984) 1.41
Fimbrial phase variation and systemic E. coli infection studied in the mouse peritonitis model. Microb Pathog (1986) 1.40
Immunization with major outer membrane protein (porin) preparations in experimental murine salmonellosis: effect of lipopolysaccharide. Infect Immun (1981) 1.40
The four subclasses of IgG can be isolated from mouse serum by using Protein A-Sepharose. Scand J Immunol (1981) 1.37
Triggering infections in reactive arthritis. Ann Rheum Dis (1985) 1.36
Antigenic properties of Chlamydia trachomatis lipopolysaccharide. Infect Immun (1985) 1.34
Determination of 19S and 7S components in an anti-hapten antibody. Ann Med Exp Biol Fenn (1967) 1.34
Complement activation by polysaccharide of lipopolysaccharide: an important virulence determinant of salmonellae. Infect Immun (1983) 1.34
Genetic determination of bacterial virulence, with special reference to Salmonella. Curr Top Microbiol Immunol (1986) 1.34
Affinity requirements for antibody assays mapped by monoclonal antibodies. J Immunol (1983) 1.33
Effect of the quality of the lipopolysaccharide on mouse virulence of Salmonella enteritidis. Infect Immun (1975) 1.32
Presence of rfe genes in Escherichia coli: their participation in biosynthesis of O antigen and enterobacterial common antigen. J Bacteriol (1976) 1.32
Participation of lipopolysaccharide genes in the determination of the entobacterial common antigen: analysis in Salmonella groups B and C1. J Bacteriol (1974) 1.32
Pneumococcal vaccine and otitis media. Lancet (1980) 1.31
rfaP mutants of Salmonella typhimurium. Eur J Biochem (1989) 1.31
Analogies between lymphocyte receptors and the resulting humoral antibodies. Transplant Rev (1970) 1.29
A mendelian idiotype is demonstrable in the heteroclitic anti-NP antibodies of the mouse. Eur J Immunol (1978) 1.29
Single lymph node cells producing heteroclitic bacteriophage antibody. J Immunol (1965) 1.28
Bacteriophage attachment to the somatic antigen of salmonella: effect of o-specific structures in leaky R mutants and s, t1 hybrids. Infect Immun (1970) 1.28
Preliminary serologic evidence for a pathogenic role of Branhamella catarrhalis. J Infect Dis (1981) 1.27
Prognosis after community-acquired pneumonia in the elderly: a population-based 12-year follow-up study. Arch Intern Med (1999) 1.26
IgG subclasses of pneumococcal antibodies--effect of allotype G2m(n). Scand J Immunol (1989) 1.26
The percentages of six immunoglobulin isotypes in human antibodies to tetanus toxoid: standardization of isotype-specific second antibodies in solid-phase assay. Eur J Immunol (1984) 1.25
The aetiology of pneumonia. Application of bacterial serology and basic laboratory methods. J Infect (1987) 1.24
Structural investigations on the core polysaccharide of Escherichia coli 0100. Eur J Biochem (1971) 1.24
Development of beta-lactamase-mediated resistance to penicillin in middle-ear isolates of Moraxella catarrhalis in Finnish children, 1978-1993. Clin Infect Dis (1995) 1.22
Cellular heterogeneity in the production of an anti-hapten antibody. J Exp Med (1967) 1.22
Enterobacterial common antigen in rfb deletion mutants of Salmonella typhimurium. J Bacteriol (1976) 1.22
Antibody response to 14-valent pneumococcal capsular polysaccharide vaccine in pre-school age children. Pediatr Infect Dis (1986) 1.22
Shift in the age-distribution of meningococcal disease as predictor of an epidemic? Lancet (1982) 1.21